Pure Global
NCT04919694

Combination of Orbital Compression Surgery and Strabismus Surgery for Thyroid Associated Ophthalmopathy

The Therapeutic Effect of Combination of Orbital Compression Surgery and Strabismus Surgery in Patients With Moderate to Severe Thyroid Associated Ophthalmopathy
Sun Yat-sen University·ClinicalTrials.gov·procedureNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Thyroid Associated Ophthalmopathy
Drug/Device/Intervention
combination of orbital compression surgery and strabismus surgery
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Sun Yat-sen University
Location
Guangzhou, China
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2021
End date
Dec 31, 2023
Enrollment
60 participants
Primary outcome

quality of life ,measured by GO-QoL(quality of life with Grave's Orbitopathy) .,quality of life, measured by GO-QoL(quality of life with Grave's Orbitopathy) .

Summary

The purpose of this study is to determine whether combination of orbital compression surgery
 with strabismus surgery is better than strabismus surgery after orbital compression surgery
 in the treatment of moderate-to-severe thyroid associated ophthalmopathy

ICD-10 classifications
ThyroiditisDisorders of thyroid glandThyroiditis, unspecifiedOther disorders of thyroidDisorder of thyroid, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04919694
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04919694 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-sen University and is currently Not yet recruiting. The study focuses on Thyroid Associated Ophthalmopathy. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.